New incident report
Incident Report Number: 2020-1502
Registrant Reference Number: 2020-US-000255
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-139
Product Name: Hartz UltraGuard Plus Flea and Tick Collar for Cats and Kittens
Other (specify)
CollarYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Cat / Chat
Domestic Shorthair
1
Male
3
12
lbs
Skin
>2 hrs <=8 hrs / >2 h <=8 h
<=30 min / <=30 min
System
Persisted until death
Yes
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 03-Jan-2020, a 3 year old, 12 pound, neutered, male, Domestic Shorthair cat, in unknown condition, with no known concomitant medical conditions, was administered 1 collar of Hartz UltraGuard Plus Flea and Tick Collar for Cats and Kittens (Tetrachlorvinphos (Rabon) / S Methoprene) via the topical route by the animal owner. At an unspecified time post product application, the cat attempted to remove the collar by scratching and biting at it. Approximately four hours post product application the collar was removed and the symptoms resolved at an unspecified time that same day. On 06-Jan-2020, the cat developed hypersalivation, inappropriate urination, inappropriate defecation and was brought to an emergency veterinary facility. The cat died while receiving unspecified treatment. It is unknown if a necropsy was performed. No further information was received.
Death
Assessment: This product is considered to have a wide margin of safety in cats. The initial signs of scratching and biting at the collar are not uncommon and may occur if the cat does not like having a collar on in general. If a small amount of product was ingested, only minor oral irritation or gastrointestinal upset resulting in drooling or vomiting would be expected. However, delayed onset hypersalivation, inappropriate urination and defecation are not expected. No conversation with the treating veterinarian occurred so it is unknown what treatments were performed and if other symptoms were observed. Other causes including GI foreign body obstruction, urinary obstruction, underlying metabolic and infectious disease should be considered in this case. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.